Factors of imatinib resistance in chronic myeloid leukemia

被引:0
|
作者
Kajtar, B. [1 ]
Alpar, D. [1 ]
Toth, J. [1 ]
Laszlo, R. [1 ]
Jakso, R. [1 ]
Kereskai, L. [1 ]
Nagy, Z. [1 ]
Pajor, L. [1 ]
机构
[1] Univ Pecs, Dept Pathol, H-7622 Pecs, Hungary
关键词
D O I
10.1016/S0268-960X(07)70053-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S78 / S78
页数:1
相关论文
共 50 条
  • [41] Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia
    Monique P. Curran
    Katherine F. Croom
    Karen L. Goa
    BioDrugs, 2004, 18 : 207 - 210
  • [42] Chronic myeloid leukemia and its treatment with imatinib
    Treuil, Pascal
    ACTUALITES PHARMACEUTIQUES, 2008, 47 (473): : 25 - 30
  • [44] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [45] Imatinib in chronic myeloid leukemia elderly patients
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Palandri, Francesca
    Baccarani, Michele
    Rosti, Gianantonio
    AGING-US, 2011, 3 (12): : 1125 - 1126
  • [46] Antituberculosis therapy and imatinib for chronic myeloid leukemia
    Sora, Federica
    De Matteis, Silvia
    Di Mario, Antonella
    Maiuro, Giuseppe
    Laurenti, Luca
    Chiusolo, Patrizia
    Ardito, Fausta
    Leone, Giuseppe
    Sica, Simona
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) : 1223 - 1224
  • [47] Imatinib mesylate and treatment of chronic myeloid leukemia
    Yamada, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [48] miRNA in chronic myeloid leukemia and imatinib response
    Dulucq, Stephanie
    Mahon, Francois Xavier
    PHARMACOGENOMICS, 2010, 11 (09) : 1201 - 1202
  • [49] Imatinib monitoring in chronic myeloid leukemia patients
    Kilic, P.
    Kayaalti, Z.
    Gunduz, M.
    Gurman, G.
    Soylemezoglu, T.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S241 - S241
  • [50] Spotlight on imatinib mesylate in chronic myeloid leukemia
    Curran, MP
    Croom, KF
    Goa, KL
    BIODRUGS, 2004, 18 (03) : 207 - 210